TY - JOUR
T1 - Simultaneous brightness discrimination and reversal
T2 - The effects of amphetamine administration in the two stages
AU - Weiner, I.
AU - Feldon, J.
AU - Ben-Shahar, O.
PY - 1986/11
Y1 - 1986/11
N2 - Rats were trained in a Y-maze on a two-choice simultaneous brightness discrimination with light as S+ and dark as S- (Stage 1), and were then switched to reversal, where the reinforcement contingencies of the original training were reversed (Stage 2). d-Ampthetamine, 1 mg/kg, was administered in a 2 × 2 design, i.e., drug-no drug in Stage 1 and drug-no drug in Stage 2. The administration of the drug in Stage 1 improved the acquisition of the initial brightness discrimination and facilitated reversal learning independently of the drug administered in Stage 2. In addition, the administration of the drug in Stage 2 only improved performance towards the end of reversal training. The results indicate that amphetamine enhances the attention to, or the associability of, the discriminative stimuli, leading to a rapid learining to these stimuli under changed contingencies of reinforcement.
AB - Rats were trained in a Y-maze on a two-choice simultaneous brightness discrimination with light as S+ and dark as S- (Stage 1), and were then switched to reversal, where the reinforcement contingencies of the original training were reversed (Stage 2). d-Ampthetamine, 1 mg/kg, was administered in a 2 × 2 design, i.e., drug-no drug in Stage 1 and drug-no drug in Stage 2. The administration of the drug in Stage 1 improved the acquisition of the initial brightness discrimination and facilitated reversal learning independently of the drug administered in Stage 2. In addition, the administration of the drug in Stage 2 only improved performance towards the end of reversal training. The results indicate that amphetamine enhances the attention to, or the associability of, the discriminative stimuli, leading to a rapid learining to these stimuli under changed contingencies of reinforcement.
KW - Rat
KW - Reversal
KW - Simultaneous brightness discrimination
KW - d-Amphetamine
UR - http://www.scopus.com/inward/record.url?scp=0022968777&partnerID=8YFLogxK
U2 - 10.1016/0091-3057(86)90066-3
DO - 10.1016/0091-3057(86)90066-3
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0022968777
SN - 0091-3057
VL - 25
SP - 939
EP - 942
JO - Pharmacology Biochemistry and Behavior
JF - Pharmacology Biochemistry and Behavior
IS - 5
ER -